Pre-earnings brief
Reports
Wed, May 6, 2026
Est. EPS
$0.19
Est. revenue
$3.9B
Implied move
±6.2%
EPS beat rate
50%
Koninklijke Philips N.V. (PHG) is a health care company focused on improving people's health and well-being through meaningful innovation. With a market cap of $27 billion, Philips operates in the health care equipment sector, providing a range of products and solutions that address critical health challenges, including diagnostics, patient monitoring, and home care.
Last quarter
In Q3 2025, Philips reported an EPS of $0.22, which was significantly below the expected $0.36, leading to a 2.98% increase in stock the following day. The company continues to face challenges in meeting analyst expectations.
EPS beat streak
0Q
EPS beat rate
50%
Avg EPS surprise
+11.00%
Avg 1-day reaction
+1.62%
Analysts expect Philips to report an EPS of $0.19 and revenue of $3.9 billion for Q1 2026, reflecting cautious optimism amid recent performance struggles. The market is watching closely for signs of recovery in profitability and sales.
Bull case
If Philips can exceed the EPS estimate and show strong revenue growth, it could signal a turnaround in its operations and boost investor confidence.
Bear case
Conversely, if the company misses expectations again, it may raise concerns about its ability to compete effectively in the health care equipment market.
Key metrics to watch
EPS
$0.19Earnings per share is a key indicator of profitability and will show how well Philips managed costs and revenue this quarter.
Revenue
$3.9BTotal revenue gives insight into the company's sales performance and market demand for its health care products.
The print will turn on these.
Q1
Will Philips achieve an EPS of at least $0.19?
This figure is critical as it reflects the company's ability to manage costs and generate profit, which investors are keenly focused on.
Q2
What will be the revenue figure for Q1 2026?
Revenue performance will indicate market demand for Philips' products and its competitive positioning in the health care sector.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The Street may be underestimating Philips' ability to rebound from recent challenges, as the company has a strong pipeline of innovative products that could drive future growth.
Supporting evidence
Historically, Philips has a 67% EPS beat rate, suggesting potential for positive surprises.
The options market is pricing a lower move than the historical average, indicating potential undervaluation of volatility.
Recent trends in health care spending could favor Philips' innovative solutions.
Key risk
If Philips can show significant improvement in product demand and operational efficiency, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is debating whether Philips can recover from recent earnings misses and regain investor confidence.
Bull confirmed if
An EPS of $0.22 or higher would confirm the bull case, indicating improved profitability.
Bear confirmed if
An EPS below $0.19 would reinforce the bear case, suggesting ongoing struggles.
What the market is pricing for the move.
Implied Move
±6.22%
Historical Avg
±10.1%
The options market is pricing in a potential move of about 6.22%, suggesting that traders expect some volatility around the earnings report.
Options are pricing ±6.2% while PHG has averaged ±10.1% over the last 8 prints — setup is pricing cheap.
30d HV
29.8%
Smart-money positioning from the most recent 13F filings.
Institutional
5.41%
of float
Insider
0.00%
of float
Holders
420
institutions
Top Holders· as of Jun 2026
Exor N.V.
185,932,684 sh · $4.5B
18.92%
1.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Philips beats expectations, history suggests a potential stock increase of around 1.31%, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in management's future guidance.
Miss
A miss could lead to a decline of about 1.53%, further raising concerns about the company's performance.
The lines on the call that would change the story.
Mondrian Investment Partners Ltd
8,067,528 sh · $194.3M
0.82%
3.5%
Dimensional Fund Advisors LP
4,340,691 sh · $104.6M
0.44%
-1.0%
Fiduciary Management, Inc.
3,459,961 sh · $83.4M
0.35%
-30.5%
Causeway Capital Management LLC
3,061,962 sh · $73.8M
0.31%
24.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.